Cleveland Clinic leads list of 25 top healthcare supply chains for 2018

Research and advisory firm Gartner has released its 10th annual HealthCare Supply Chain Top 25 rankings for 2018, recognizing health systems or healthcare companies for their efforts to improve human life at sustainable costs.

“In order to be successful, supply chains must sport a specific skill set that consists of patient focus, collaboration and network visibility,” said Stephen Meyer, senior director at Gartner. “The top supply chains in this year’s ranking have embraced those skills and excelled in executing them.”

Cleveland Clinic earned the top spot this year, climbing from No. 8 in 2017. The organization has been in the top 10 of the rankings for the last three years and has shown continuous efforts to improve through innovation.

The complete list:

1. Cleveland Clinic

2. CVS Health (Woonsocket, R.I.)

3. Johnson & Johnson (New Brunswick, N.J.)

4. Mercy Health (St. Louis)

5. McKesson (San Francisco)

6. AmerisourceBergen (Chesterbrook, Pa.)

7. Walgreens Boots Alliance (Deerfield, Ill.)

8. Medtronic (Dublin, Ireland)

9. Banner Health (Phoenix)

10. Duke University Health System (Durham, N.C.)

11. Ochsner Health System (New Orleans)

12. BD (Franklin Lakes, N.J.)

13. Advocate Health Care (Downers Grove, Ill.)

14. Henry Schein (Melville, N.Y.)

15. Stryker (Kalamazoo, Mich.)

16. Ascension Health (St. Louis)

17. Pfizer (New York City)

18. Novo Nordisk (Bagsvaerd, Denmark)

19. Novartis (Basel, Switzerland)

20. Abbott Laboratories (Abbott Park, Ill.)

21. Bristol-Myers Squibb (New York City)

22. GlaxoSmithKline (Brentford, England)

23. AbbVie (North Chicago, Ill.)

24. Spectrum Health (Grand Rapids, Mich.)

READ  Diet rich in fruits and vegetables tied to fewer menopause symptoms

25. Providence St. Joseph Health (Renton, Wash.)

More articles on supply chain:
First FDA-cleared ‘digital therapeutic’ for substance use disorder launches
Software issues drive medical device recalls for 10th consecutive quarter, report finds
FDA’s cybersecurity policies for postmarket medical devices are ‘insufficient,’ OIG finds


© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

Source link

Rating: 4.10 from 5 (12 reviews)